The majority of a hospital-based population accepted to participate in a molecular screening project for familial breast cancer, giving their informed consent to blood sampling. Only 9.5% of patients declined to sign the consent form. Here we report the reasons for refusal and we critically review our methodological approach to obtain consent for a blood test for genetic research in a clinical setting.
FordD., EastonD.F., StrattonM., NarodS., GoldgarD., DevileeP., BishopD.T., WeberB., LenoirG., Chang-ClaudeJ., SobolH., TeareM.D., StruewingJ., ArasonA., ScherneckS., PetoJ., RebbeckT.R., ToninP., NeuhausenS., BarkardottirR., EyfjordJ., LynchH., PonderB.A., GaytherS.A., Zelada-HedmanM.: Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet, 62: 676–689, 1998.
2.
ScheuerL., KauffN., RobsonM., KellyB., BarakatR., SatagopanJ., EllisN., HensleyM., BoydJ., BorgenP., NortonL., OffitK.: Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers. J Clin Oncol, 20: 1260–1268, 2002.
3.
PichertG., BolligerB., BuserK., PaganiO.: Swiss Institute for Applied Cancer Research Network for Cancer Predisposition Testing and Counseling. Evidence-based management options for women at increased breast/ovarian cancer risk. Ann Oncol, 14: 9–19, 2003.
4.
WangS.S., FridingerF., SheedyK.M., KhouryM.J.: Public attitudes regarding the donation and storage of blood specimens for genetic research. Community Genet, 4: 18–26, 2001.
5.
McQuillanG.M., PorterK.S., AgelliM., KingtonR.: Consent for genetic research in a general population: the NHANES experience. Genet Med, 5: 35–42, 2003.
6.
SchwartzM.D., RothenbergK., JosephL., BenkendorfJ., LermanC.: Consent to the use of stored DNA for genetics research: a survey of attitudes in the Jewish population. Am J Med Genet, 98: 336–342, 2001.
7.
PapelardH., de BockG.H., van EijkR., Vliet VlielandT.P., CornelisseC.J., DevileeP., TollenaarR.A.: Prevalence of BRCA1 in a hospital-based population of Dutch breast cancer patients. Br J Cancer, 83: 719–724, 2000.
8.
BrunoM., TommasiS., CicoriaA., RinaldiM., ParadisoA., SchittulliF.: Genetic testing for hereditary breast cancer: what interest in the general population?Eur J Oncol, 8: 95–98, 2003.
9.
BrunoM., TommasiS., SteaB., QuarantaM., SchittulliF., MastropasquaA., DistanteA., Di PaolaL., ParadisoA.: Awareness of breast cancer genetics and interest in predictive genetic testing: a survey in Southern Italian population. Proc Second Annual AACR International Conference on Frontiers in Cancer Prevention Research, Phoenix, AZ, USA. Abstract C107, 2003.
